Science’s new bottleneck is not discovery. It is deployment.

In 2026, the frontier of science is less about isolated breakthroughs than about whether promising results can survive the journey into clinical, industrial, and institutional reality. Gene editing, early cancer detection, AI-enabled discovery, and space data are converging on one test: can modern science scale without losing reliability?